These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19519386)

  • 41. Targeting metabotropic glutamate receptors in the treatment of epilepsy: rationale and current status.
    Celli R; Santolini I; Van Luijtelaar G; Ngomba RT; Bruno V; Nicoletti F
    Expert Opin Ther Targets; 2019 Apr; 23(4):341-351. PubMed ID: 30801204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anticonvulsant activity of a mGlu(4alpha) receptor selective agonist, (1S,3R,4S)-1-aminocyclopentane-1,2,4-tricarboxylic acid.
    Chapman AG; Talebi A; Yip PK; Meldrum BS
    Eur J Pharmacol; 2001 Jul; 424(2):107-13. PubMed ID: 11476756
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distinct influence of the group III metabotropic glutamate receptor agonist (R,S)-4-phosphonophenylglycine [(R,S)-PPG] on different forms of neuronal damage.
    Henrich-Noack P; Flor PJ; Sabelhaus CF; Prass K; Dirnagl U; Gasparini F; Sauter A; Rudin M; Reymann KG
    Neuropharmacology; 2000 Mar; 39(5):911-7. PubMed ID: 10699457
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The neuroprotective effects of orthosteric agonists of group II and III mGluRs in primary neuronal cell cultures are dependent on developmental stage.
    Jantas D; Gręda A; Gołda S; Korostyński M; Lasoń W
    Neuropharmacology; 2016 Dec; 111():195-211. PubMed ID: 27600687
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional role of mGluR1 and mGluR4 in pilocarpine-induced temporal lobe epilepsy.
    Pitsch J; Schoch S; Gueler N; Flor PJ; van der Putten H; Becker AJ
    Neurobiol Dis; 2007 Jun; 26(3):623-33. PubMed ID: 17446080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Possible involvement of group I mGluRs in neuroprotective effect of theanine.
    Nagasawa K; Aoki H; Yasuda E; Nagai K; Shimohama S; Fujimoto S
    Biochem Biophys Res Commun; 2004 Jul; 320(1):116-22. PubMed ID: 15207710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quinolinic acid promotes seizures and decreases glutamate uptake in young rats: reversal by orally administered guanosine.
    de Oliveira DL; Horn JF; Rodrigues JM; Frizzo ME; Moriguchi E; Souza DO; Wofchuk S
    Brain Res; 2004 Aug; 1018(1):48-54. PubMed ID: 15262204
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabotropic glutamate receptors as a target for anticonvulsant and anxiolytic action in immature rats.
    Mares P; Mikulecká A; Tichá K; Lojková-Janecková D; Kubová H
    Epilepsia; 2010 Jul; 51 Suppl 3():24-6. PubMed ID: 20618395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential effects of metabotropic glutamate receptor antagonists on bursting activity in the amygdala.
    Keele NB; Neugebauer V; Shinnick-Gallagher P
    J Neurophysiol; 1999 May; 81(5):2056-65. PubMed ID: 10322047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats.
    Langer M; Brandt C; Zellinger C; Löscher W
    Neuropharmacology; 2011; 61(5-6):1033-47. PubMed ID: 21736883
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Models in research of pharmacoresistant epilepsy: present and future in development of antiepileptic drugs.
    Kovács R; Heinemann U
    Curr Med Chem; 2014; 21(6):689-703. PubMed ID: 24251565
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiepileptic drugs in neuroprotection.
    Pitkänen A; Kubova H
    Expert Opin Pharmacother; 2004 Apr; 5(4):777-98. PubMed ID: 15102563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The anticonvulsant activity and cerebral protection of chronic lithium chloride via NMDA receptor/nitric oxide and phospho-ERK.
    Mohammad Jafari R; Ghahremani MH; Rahimi N; Shadboorestan A; Rashidian A; Esmaeili J; Ejtemaei Mehr S; Dehpour AR
    Brain Res Bull; 2018 Mar; 137():1-9. PubMed ID: 29102713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional roles of benzothiazole motif in antiepileptic drug research.
    Amir M; Hassan MZ
    Mini Rev Med Chem; 2013 Dec; 13(14):2060-75. PubMed ID: 24251804
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu(1) receptor antagonist BAY 36-7620.
    De Vry J; Horváth E; Schreiber R
    Eur J Pharmacol; 2001 Oct; 428(2):203-14. PubMed ID: 11675037
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of current antiepileptics to prevent neurodegeneration in epilepsy models.
    Pitkänen A
    Epilepsy Res; 2002 Jun; 50(1-2):141-60. PubMed ID: 12151125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. BW1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdala-kindling model of epilepsy.
    Morimoto K; Sato H; Sato K; Sato S; Yamada N
    Eur J Pharmacol; 1997 Nov; 339(1):11-5. PubMed ID: 9450611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disruption of the GluA2/GAPDH complex using TAT-GluA2NT1-3-2 peptide protects against AMPAR-mediated excitotoxicity after epilepsy.
    Zhang J; Qiao N; Ding X; Wang J
    Neuroreport; 2018 Mar; 29(5):432-439. PubMed ID: 29489588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-inflammatory drugs in epilepsy: does it impact epileptogenesis?
    Vezzani A
    Expert Opin Drug Saf; 2015 Apr; 14(4):583-92. PubMed ID: 25645535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuroprotective activity of metabotropic glutamate receptor ligands.
    Flor PJ; Battaglia G; Nicoletti F; Gasparini F; Bruno V
    Adv Exp Med Biol; 2002; 513():197-223. PubMed ID: 12575822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.